Definiens, MolecularMD Announce Partnership
News Jun 03, 2016
Definiens has announced a partnership agreement with MolecularMD to combine MolecularMD’s expertise in specialty diagnostic assays with Definiens’ quantitative tissue read-outs. MolecularMD is a molecular diagnostics company that develops custom companion diagnostic products and supports clinical trial services for targeted cancer therapies.
“Definiens’ technology already empowers smarter tissue-based diagnostics,” said Merrilyn Datta, chief commercial officer, Definiens. “This agreement brings together MolecularMD’s proven track record in clinical assay development and companion diagnostics with Definiens’ unparalleled image analysis platform to provide the confidence of an integrated solution in stratifying patients.”
The new partnership between the two diagnostics companies provides custom solutions that meet data and regulatory requirements for both biopharmaceutical clients and academic medical center oncology programs, including advanced solutions with assays, image analysis and data mining, combined with deep scientific, regulatory and pathology support.
“MolecularMD is uniquely suited to assist biopharmaceutical clients and academic medical centers with our clinical trial and regulatory expertise,” said Dan Snyder, president and chief executive officer, MolecularMD. “I’m thrilled that Definiens and MolecularMD have joined forces to provide these unique advantages, accelerating pipeline decisions and dramatically improving patient stratification from the pre-clinical phase.”
Liquid Biopsy Can Help Predict Outcomes in Metastatic Triple-Negative Breast CancerNews
A clinically relevant “liquid biopsy” test can be used to profile cancer genomes from blood and predict survival outcomes for patients with metastatic triple negative breast cancer.READ MORE
Researchers Discover Key Link Between Mitochondria and Cocaine AddictionNews
Researchers were able to block response in mitochondria to cocaine.READ MORE
Fraunhofer and Mologic Partner on Point-of-Care Diagnosis and Antibiotic Susceptibility Test for UTIsNews
Test will allow better targeting of prescription antibiotics and address growing antimicrobial resistance.READ MORE